Thompson Elizabeth H.Z.
EVP, Head of Research & Dev
Thompson Elizabeth H.Z. has filed 2 SEC Form 4 filings (5 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Jul 31, 2026.
On the most recent filing, Thompson Elizabeth H.Z. is listed as EVP, Head of Research & Dev at ACADIA PHARMACEUTICALS INC. Inside the rolling window, Thompson Elizabeth H.Z. reported no open-market purchases and 2 open-market sales totaling $506K in ACAD. The largest disclosed transaction in the window is a sale of 16,558 ACAD shares on Jul 30, 2026, worth $433K.
Companies traded
Other insiders at ACAD
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$506K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Thompson Elizabeth H.Z. made?
Thompson Elizabeth H.Z. has filed 2 SEC Form 4 filings (5 transaction rows) across 1 company since 2026.
Which companies does Thompson Elizabeth H.Z. trade?
Thompson Elizabeth H.Z. has filed SEC Form 4 disclosures for 1 company, including ACAD.
When was Thompson Elizabeth H.Z.'s most recent SEC Form 4 filing?
Thompson Elizabeth H.Z.'s most recent SEC Form 4 filing on Tracefour is dated Jul 31, 2026.
What is Thompson Elizabeth H.Z.'s job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Thompson Elizabeth H.Z. is listed as EVP, Head of Research & Dev.
What is Thompson Elizabeth H.Z.'s total buy and sell value in the current window?
Inside the rolling retention window, Thompson Elizabeth H.Z. bought $0 and sold $506K based on SEC Form 4 filings.
What was Thompson Elizabeth H.Z.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 16,558 ACAD shares on 2026-07-30, worth $433K, per SEC Form 4 filings.